Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 13.33 USD -0.15% Market Closed
Market Cap: 315.5m USD

Tactile Systems Technology Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tactile Systems Technology Inc
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Total Receivables
$44.9m
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Receivables
$2.6B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Total Receivables
$2.5B
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Total Receivables
$4B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Total Receivables
$6.9B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Receivables
$1.2B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
15%

Tactile Systems Technology Inc
Glance View

Market Cap
318.4m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
16.16 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Tactile Systems Technology Inc's Total Receivables?
Total Receivables
44.9m USD

Based on the financial report for Dec 31, 2024, Tactile Systems Technology Inc's Total Receivables amounts to 44.9m USD.

What is Tactile Systems Technology Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
6%

Over the last year, the Total Receivables growth was 4%. The average annual Total Receivables growth rates for Tactile Systems Technology Inc have been -3% over the past three years , 6% over the past five years .

Back to Top